Tripelennamine

CHEMBL1241 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
255.4 g/mol
LogP
3.3
Phase
4

Tripelennamine is a first-generation H1 antihistamine that competitively blocks histamine at H1 receptors, reducing allergic symptoms such as itching, urticaria, rhinorrhea, and conjunctivitis. It has significant sedative and anticholinergic properties due to central nervous system penetration. It was used for allergic conditions and as a component in some illicit drug preparations due to its CNS effects.

Khối lượng phân tử

255,3600 g/mol

LogP

3,30

TPSA

19,40 Ų

Lipinski RO5

Đạt

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCN(Cc1ccccc1)c1ccccn1

InChI

InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3

Molecular Formula

C16H21N3

HBD / HBA

- / 3

Liên kết có thể quay

6

Nguyên tử nặng

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

Tripelennamine is a first-generation H1 antihistamine that competitively blocks histamine at H1 receptors, reducing allergic symptoms such as itching, urticaria, rhinorrhea, and conjunctivitis. It has significant sedative and anticholinergic properties due to central nervous system penetration. It was used for allergic conditions and as a component in some illicit drug preparations due to its CNS effects.

Yes, Tripelennamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1241. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5587. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.